Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
347.20    -0.20 (-0.06%)
Bid:
347.20
Ask:
347.60
Spread: 0.40 (0.115%)
Market Cap: £2.54b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Director Declaration

16 Nov 2018 15:42

RNS Number : 6692H
TP ICAP PLC
16 November 2018
 

TP ICAP PLC

 

16 November 2018

 

TP ICAP plc confirms regulatory approval of Nicolas Breteau

 

Following the appointment of Nicolas Breteau as Chief Executive on 10 July 2018, TP ICAP plc (the "Company") is pleased to confirm that on 14 November 2018 it received regulatory approval from the Financial Conduct Authority of Mr Breteau's appointment as Executive Director (CF1) at Tullet Prebon (Securities) Limited, ICAP Securities Limited and iSwap Euro Limited.

 

There are no other details that are required to be disclosed in respect of Mr Breteau's appointment under Paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

 

ENDS

 

Media enquiries:

 

Jamie Dunkley

Jamie.Dunkley@tpicap.com

+44 (0) 20 7200 7524

 

About TPICAP

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

 

About Nicolas Breteau

Nicolas Breteau has extensive experience across the global broking industry. He joined Tullett Prebon as Chief Commercial Officer in 2016, and then moved to run TP ICAP's largest business, Global Broking.

Nicolas started his career in 1993 on the Listed Derivatives Exchange MATIF (later part of Euronext). From 1993 to 1998, he held several senior positions at the derivatives broker FIMAT, including Deputy CEO of the

Paris Office. He then moved to London as Head of Risk for EMEA, and subsequently became Deputy CEO then CEO of the FIMAT London Branch.

In 2005, Nicolas was promoted to CEO of EMEA, a position he consolidated after Newedge was formed through the merger of FIMAT with Calyon Financial in 2008. He was appointed Global Head of Sales and Front-Office in 2009 and became Chief Executive of Newedge Group in 2010. He moved from Newedge in 2014 following the sale of the company to Société Générale, and became Senior Managing Partner of a consulting firm, 99 Advisory.

Nicolas graduated from Ecole Superieure de Commerce de Bordeaux. He has been a director of several Boards including the Futures and Options Association (UK), Futures Industry Association (USA), Altura (Spain), Citic/Newedge (China) and has been the chairman of i-swap since February 2018.

He is a trustee at PSE For a Child's Smile UK, which helps deprived children in Cambodia.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNUNSVRWRAAAAA
Date   Source Headline
1st Apr 20216:15 pmRNSDirector/PDMR Shareholding
26th Mar 20212:05 pmRNSAnnual Financial Report
10th Mar 20215:16 pmRNSRe-registration and name change
9th Mar 20217:03 amRNSFinal Results
26th Feb 20218:24 amRNSScheme Effective and Admission
24th Feb 20214:24 pmRNSCourt Sanction of the Scheme of Arrangement
18th Feb 20214:20 pmRNSHolding(s) in Company
17th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Feb 20214:00 pmRNSTotal Voting Rights
17th Feb 202111:12 amRNSResults of Rump Placing
17th Feb 20217:00 amRNSResults of Rights Issue
16th Feb 20212:56 pmRNSHolding(s) in Company
2nd Feb 20218:00 amRNSAdmission of Nil Paid Rights
1st Feb 20214:05 pmRNSResults of Court Meeting and General Meeting
1st Feb 20213:55 pmRNSResult of General Meeting - Liquidnet Acquistion
29th Jan 20211:05 pmRNSPublication of Suppl.Prospcts
25th Jan 20217:00 amRNSUpdate on Brexit Readiness Plan
7th Jan 20211:44 pmRNSCorporate Reorganisation - Documents Publication
7th Jan 20211:40 pmRNSPublication of Prospectus and Circular
7th Jan 20217:00 amRNSAnnouncement re: Rights Issue
7th Jan 20217:00 amRNSTrading Statement
17th Dec 202012:25 pmRNSHolding(s) in Company
15th Dec 20203:55 pmRNSHolding(s) in Company
1st Dec 20207:00 amRNSTP ICAP plc hosts its 2020 Capital Markets Day
23rd Nov 202012:39 pmRNSChanges to Committee Membership
12th Nov 20204:24 pmRNSDirector/PDMR Shareholding
10th Nov 20204:28 pmRNSHolding(s) in Company
9th Nov 20207:00 amRNSTrading Statement
3rd Nov 20205:11 pmRNSHolding(s) in Company
30th Oct 20203:38 pmRNSTotal Voting Rights
23rd Oct 202012:13 pmRNSHolding(s) in Company
14th Oct 20205:24 pmRNSDirector/PDMR Shareholding
13th Oct 20204:08 pmRNSDirector/PDMR Shareholding
12th Oct 20203:29 pmRNSDirector/PDMR Shareholding
9th Oct 20203:07 pmRNSDirector/PDMR Shareholding
9th Oct 20207:00 amRNSProposed Acquisition of Liquidnet
29th Sep 20206:26 pmRNSDiscussions re proposed acquisition of Liquidnet
10th Sep 20202:45 pmRNSDirectorate Change
7th Aug 20207:00 amRNSFinancial and Interim Management Report
31st Jul 20201:43 pmRNSAcquisition of Louis Capital
31st Jul 20207:00 amRNSDirectorate Change
6th Jul 202010:58 amRNSHolding(s) in Company
6th Jul 202010:49 amRNSHolding(s) in Company
25th Jun 20208:56 amRNSHolding(s) in Company
24th Jun 202010:31 amRNSDirector/PDMR Shareholding
23rd Jun 20205:18 pmRNSHolding(s) in Company
17th Jun 202012:09 pmRNSHolding(s) in Company
13th May 20206:08 pmRNSResult of AGM
13th May 20207:00 amRNSTrading Update Q1 2020
12th May 20204:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.